Sustained release spherical agglomerates of polymethacrylates containing mefenamic acid: in vitro release, micromeritic properties and histological studies

References

• Usha AN, Mutalik S, Reddy MS, Ranjith AK, Kushtagi P, Udupa N. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates. Eur J Pharm Biopharm 2008;70:674–683.
   PubMed Web of Science ®Google Scholar
• Szabo-Revesz P, Hodi KP, Eros I, Farkas B. Development of spherical crystal agglomerates of an aspartic acid salt for direct tablet making. Powder Technol 2001;114:118–124.
   Web of Science ®Google Scholar
• Paradkar AR, Pawar AP, Chordiya JK, Patil VB, Ketkar AR. Spherical crystallization of celecoxib. Drug Dev Ind Pharm 2002;28:1213–1220.
   PubMed Web of Science ®Google Scholar
• Paradkar AR, Mahadik KR, Pawar AP. Spherical crystallization a novel particle design technique. Indian Drugs 1998;31:283–299.
   Google Scholar
• Kawashima Y, Imai M, Takeuchi H, Yamamoto H, Kamiya K, Hino T. Improved flowability and compactibility of spherically agglomerated crystals of ascorbic acid for direct tableting designed by spherical crystallization process. Powder Technol 2003;130:283–289.
   Web of Science ®Google Scholar
• Kumar S, Chawla G, Bansal AK. Spherical crystallization of mebendazole to improve processability. Pharm Dev Technol 2008;13:559–568.
   PubMed Web of Science ®Google Scholar
• Maghsoodi M, Hassan-Zadeh D, Barzegar-Jalali M, Nokhodchi A, Martin G. Improved compaction and packing properties of naproxen agglomerated crystals obtained by spherical crystallization technique. Drug Dev Ind Pharm 2007;33:1216–1224.
   PubMed Web of Science ®Google Scholar
• Sevgi F, Sarpaş B, Yurdasiper A. The effect of tabletting on the release characteristics of mefenamic acid microspheres. European Conference on Drug Delivery and Pharmaceutical Technology, 10–12 May, Sevilla, Spain, 2004:139.
   Google Scholar
• Akbuğa J. Preparation and evaluation of controlled release furosemide microspheres by spherical crystallization. Int J Pharm 1989;53:99–105.
   Web of Science ®Google Scholar
• Viswanathan CL, Kulkarni SK, Kolwankar DR. Spherical agglomeration of mefenamic acid and nabumetone to improve micromeritics and solubility: a technical note. AAPS PharmSciTech 2006;7:E48.
   Google Scholar
• Bhadra S, Kumar M, Jain S, Agrawal S, Agrawal GP. Spherical crystallization of mefenamic acid. Pharm Tech Feb 2004;66–76.
   Google Scholar
• The Merck Index, 13th edition. Merck Co. Inc., 2001.
   Google Scholar
• Martindale, The Extra Pharmacopeia, 32nd edition. Martindale Pharmaceutical Press, London, 2001.
   Google Scholar
• Ozsoy Y, Bergisadi N. Preparation of mefenamic acid sustained release beads based on kappa-carrageenan. Boll Chim Farm 2000;139:120–123.
   PubMedGoogle Scholar
• Güngör S, Yildiz A, Ozsoy Y, Cevher E, Araman A. Investigations on mefenamic acid sustained release tablets with water-insoluble gel. Farmaco 2003;58:397–401.
   PubMedGoogle Scholar
• Sevgi F, Kaynarsoy B, Ertan G. An anti-inflammatory drug (mefenamic acid) incorporated in biodegradable alginate beads: development and optimization of the process using factorial design. Pharm Dev Technol 2008;13:5–13.
   PubMed Web of Science ®Google Scholar
• Kibbe AH. Handbook of Pharmaceutical Excipients. American Pharmaceutical Association and Pharmaceutical Press, Washington, 2000.
   Google Scholar
• Eudragit Data Sheets. Röhm Pharma GmbH, Darmstadt, 1991.
   Google Scholar
• Benita S, Hoffman A, Donbrow M. Microencapsulation of paracetamol using polyacrylate resins (Eudragit Retard), kinetics of drug release and evaluation of kinetic model. J Pharm Pharmacol 1985;37:391–395.
   PubMed Web of Science ®Google Scholar
• Ho C, Hwang GC. Development of extended-release solid dispersions of nonsteroidal antiinflammatory drugs with aqueous polymeric dispersions: optimization of drug release via a curve-fitting technique. Pharm Res 1992;9:206–210.
   PubMedGoogle Scholar
• Pignatello R, Vandelli MA, Giunchedi P, Puglisi G. Properties of tolmetin-loaded Eudragit RL100 and Eudragit RS100 microparticles prepared by different techniques. STP Pharm Sci 1997;7:148–157.
   Google Scholar
• Sauer D, Watts AB, Coots LB, Zheng WC, McGinity JW. Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55. Int J Pharm 2009;367:20–28.
   PubMed Web of Science ®Google Scholar
• Maghsoodi M, Esfahani M. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique. Pharm Dev Technol 2009;14:442–450.
   PubMed Web of Science ®Google Scholar
• Imai T, Nohdomi K, Acartürk F, Otagiri M. Enhancement of dissolution and absorption of mefenamic acid by egg albumin. J Pharm Sci 1991;80:484–487.
   PubMed Web of Science ®Google Scholar
• Mizuno N, Shinkuma D, Hamaguchi T. [Variance of bioavailability of pharmaceutical preparations and analysis of factors affecting it]. Yakugaku Zasshi 2003;123:477–493.
   PubMedGoogle Scholar
• Khan MS, Akhter M. Glyceride derivatives as potential prodrugs: synthesis, biological activity and kinetic studies of glyceride derivatives of mefenamic acid. Pharmazie 2005;60:110–114.
   PubMedGoogle Scholar
• Nokhodchi A, Maghsoodi M, Hassan-Zadeh D, Barzegar-Jalali M. Preparation of agglomerated crystals for improving flowability and compactibility of poorly flowable and compactible drugs and excipients. Powder Technol 2007;175:73–81.
   Web of Science ®Google Scholar
• Gupta VR, Mutalik S, Patel MM, Jani GK. Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties. Acta Pharm 2007;57:173–184.
   PubMedGoogle Scholar
• Banga S, Chawla G, Varandani D, Mehta BR, Bansal AK. Modification of the crystal habit of celecoxib for improved processability. J Pharm Pharmacol 2007;59:29–39.
   PubMed Web of Science ®Google Scholar
• Di Martino P, Barthélémy C, Piva F, Joiris E, Palmieri GF, Martelli S. Improved dissolution behavior of fenbufen by spherical crystallization. Drug Dev Ind Pharm 1999;25:1073–1081.
   PubMed Web of Science ®Google Scholar
• Maghsoodi M, Sadeghpoor F. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique. Drug Dev Ind Pharm 2010;36:917–925.
   PubMed Web of Science ®Google Scholar
• Muatlik S, Usha AN, Reddy MS, Ranjith AK, Pandey S. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies. Pak J Pharm Sci 2007;20:218–226.
   PubMed Web of Science ®Google Scholar
• Cui F, Yang M, Jiang Y, Cun D, Lin W, Fan Y et al. Design of sustained-release nitrendipine microspheres having solid dispersion structure by quasi-emulsion solvent diffusion method. J Control Release 2003;91:375–384.
   PubMed Web of Science ®Google Scholar
• Perumal D. Microencapsulation of ibuprofen and Eudragit RS 100 by the emulsion solvent diffusion technique. Int J Pharm 2001;218:1–11.
   PubMed Web of Science ®Google Scholar
• Kachrimanis K, Ktistis G, Malamataris S. Crystallisation conditions and physicomechanical properties of ibuprofen-Eudragit® S100 spherical crystal agglomerates prepared by the solvent-change technique. Int J Pharm 1998;173:61–74.
   Web of Science ®Google Scholar
• Kawashima Y, Niwa T, Handa T, Takeuchi H, Iwamoto T, Itoh K. Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method. J Pharm Sci 1989;78:68–72.
   PubMed Web of Science ®Google Scholar
• Wagner JG. Biopharmaceutics and Relevant Pharmacokinetics. Drug Intelligence Publications, Illinois, 1971:115–118.
   Google Scholar
• Goodman GA, Goodman LS, Rall TW, Murad F. The Pharmacological Basis of Therapeutics, 7th edition. Macmillan Publishing Company, New York, 1985.
   Google Scholar
• Sevgi F, Sarpaş B. The effect of stirring rate on the release characteristics of mefenamic acid microspheres. The 4th International Postgraduate Research Symposium on Pharmaceutics IPORSHIP 2004, 20–22 September, Istanbul, Turkey, 2004, Acta Pharmaceutica Turcica, Suppl. 2004:99.
   Google Scholar
• Sevgi F, Sarpaş B, Yurdasiper A. Sustained release formulations of tabletted mefenamic acid microspheres: effect of compression pressure. Proceedings of 12th International Pharmaceutical Technology Symposium (IPTS), 12–15 September, Istanbul, Turkey, 2004:191–192.
   Google Scholar
• Mateovic T, Kriznar B, Bogataj M, Mrhar A. The influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres. J Microencapsul 2002;19:29–36.
   PubMed Web of Science ®Google Scholar
• The United States Pharmacopoeia, USP 28− NF 23. United States Pharmacopoeial Convention Inc., Rockville, 2005.
   Google Scholar
• Wadke DA, Serajuddin ATM, Jacobson H. Preformulation testing: In: Liebermann HA, Lachman L, Schwartz JB, eds. Pharmaceutical Dosage Forms: Tablets. Vol. 1. Marcel Dekker Inc., New York, 1990:1–75.
   Google Scholar
• Pignatello R, Ferro M, De Guidi G, Salemi G, Vandelli MA, Guccione S et al. Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100 and RL100. Int J Pharm 2001;218:27–42.
   PubMed Web of Science ®Google Scholar
• Kachrimanis K, Nikolakakis I, Malamataris S. Spherical crystal agglomeration of ibuprofen by the solvent-change technique in presence of methacrylic polymers. J Pharm Sci 2000;89:250–259.
   PubMed Web of Science ®Google Scholar
• Haznedar S, Dortunç B. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm 2004;269:131–140.
   PubMed Web of Science ®Google Scholar
• Ré MI, Biscans B. Preparation of microspheres of ketoprofen with acrylic polymers by a quasi-emulsion solvent diffusion method. Powder Techn 1999;101:120–133.
   Web of Science ®Google Scholar
• Kawashima Y, Cui F, Takeuchi H, Niwa T, Hino T, Kiuchi K. Parameters determining the agglomeration behaviour and the micromeritic properties of spherically agglomerated crystals prepared by the spherical crystallization technique with miscible solvent systems. Int J Pharm 1995;119:139–147.
   Google Scholar
• Wu PC, Huang YB, Chang JS, Tsai MJ, Tsai YH. Design and evaluation of sustained release microspheres of potassium chloride prepared by Eudragit. Eur J Pharm Sci 2003;19:115–122.
   PubMed Web of Science ®Google Scholar
• Özyazıcı M, Sevgi F, Ertan G. Micromeritic studies on nicardipine hydrochloride microcapsules. Int J Pharm 1996;138:25–35.
   Web of Science ®Google Scholar
• Davis SS. The design and evaluation of controlled release systems for the gastrointestinal tract. J Control Release 1985;2:27–38.
   Google Scholar
• Ammar HO, Khalil RM. Preparation and evaluation of sustained release solid dispersions of drugs with Eudragit polymers. Drug Dev Ind Pharm 1997;23:1043–1054.
   Web of Science ®Google Scholar
• Patel VM, Prajapati BG, Patel MM. Effect of hydrophilic polymers on buccoadhesive Eudragit patches of propranolol hydrochloride using factorial design. AAPS PharmSciTech 2007;8: Article 45.
   Google Scholar
• Dechesne JP. A new enteric tablet of acetylsalicylic acid. I. Technological aspects. Int J Pharm 1987;37:203–209.
   Web of Science ®Google Scholar
• Cruz L, Assumpção E, Andrade SF, Conrado DJ, Guterres SS, Pohlmann AR. Microencapsulation of sodium alendronate reduces drug mucosal damage in rats. Drug Deliv 2010;17:231–237.
   PubMed Web of Science ®Google Scholar
• Yegin BA, Moulari B, Durlu-Kandilci NT, Korkusuz P, Pellequer Y, Lamprecht A. Sulindac loaded alginate beads for a mucoprotective and controlled drug release. J Microencapsul 2007;24:371–382.
   PubMed Web of Science ®Google Scholar
• Nagda C, Chotai N, Patel S, Nagda D, Patel U, Soni T. Chitosan microspheres of aceclofenac: in vitro and in vivo evaluation. Pharm Dev Technol 2010;15:442–451.
   PubMed Web of Science ®Google Scholar